Is NVNBW or JEPQ a better dividend investment in 2026?

NVNBW currently yields 28571.43% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: NVNBW offers higher current income.

What is the dividend yield difference between NVNBW and JEPQ?

NVNBW has a forward dividend yield of 28571.43% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 28560.33 percentage points.

Home › Compare › NVNBW vs JEPQ

NVNBW vs JEPQ: Dividend Comparison 2026

NVNBW yields 28571.43% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NVNBW wins by $1.8174438113797412e+21M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NVNBW

● Live price

28571.43%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.8174438113797412e+21M

Annual income

$1,805,016,220,998,010,500,000,000,000.00

Full NVNBW calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — NVNBW vs JEPQ

📍 NVNBW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NVNBW	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NVNBW + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NVNBW pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVNBW

Annual income on $10K today (after 15% tax)

$2,428,571.43/yr

After 10yr DRIP, annual income (after tax)

$1,534,263,787,848,309,000,000,000,000.00/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, NVNBW beats the other by $1,534,263,787,848,309,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVNBW + JEPQ for your $10,000?

NVNBW: 50%JEPQ: 50%

100% JEPQ50/50100% NVNBW

Portfolio after 10yr

$908721905689870598144.00M

Annual income

$902,508,110,499,005,300,000,000,000.00/yr

Blended yield

99.32%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVNBW buys

JEPQ buys

No recent congressional trades found for NVNBW or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNVNBWJEPQ

Forward yield	28571.43% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1.8174438113797412e+21M	$44.8K ✓
Annual income after 10y	$1,805,016,220,998,010,500,000,000,000.00 ✓	$2,152.59
Total dividends collected	$1.816625906206534e+21M	$16.3K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: NVNBW vs JEPQ ($10,000, DRIP)

Year	NVNBW Portfolio	NVNBW Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$2,867,843	$2,857,142.86	$11,930	$1,110.39	+$2.86M → NVNBW
2	$768,847,726	$765,779,134.08	$14,133	$1,224.34	+$768.83M → NVNBW
3	$192,691,632,776	$191,868,965,708.97	$16,632	$1,340.46	+$192691.62M → NVNBW
4	$45,147,257,398,343	$44,941,077,351,272.53	$19,454	$1,457.97	+$45147257.38M → NVNBW
5	$9,889,057,995,779,864	$9,840,750,430,363,638.00	$22,626	$1,576.08	+$9889057995.76M → NVNBW
6	$2,025,084,628,942,200,600	$2,014,503,336,886,716,000.00	$26,175	$1,694.09	+$2025084628942.17M → NVNBW
7	$387,709,524,857,534,600,000	$385,542,684,304,566,450,000.00	$30,133	$1,811.32	+$387709524857534.63M → NVNBW
8	$69,399,422,486,233,860,000,000	$68,984,573,294,636,305,000,000.00	$34,531	$1,927.17	+$69399422486233856.00M → NVNBW
9	$11,614,570,450,215,628,000,000,000	$11,540,313,068,155,356,000,000,000.00	$39,403	$2,041.08	+$11614570450215628800.00M → NVNBW
10	$1,817,443,811,379,741,200,000,000,000	$1,805,016,220,998,010,500,000,000,000.00	$44,787	$2,152.59	+$1.8174438113797412e+21M → NVNBW

NVNBW vs JEPQ: Complete Analysis 2026

NVNBW — Stock

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Full NVNBW Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this NVNBW vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVNBW vs SCHD NVNBW vs JEPI NVNBW vs O NVNBW vs KO NVNBW vs MAIN NVNBW vs XYLD NVNBW vs QYLD NVNBW vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.